rs10466026

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_022124.6(CDH23):​c.6130G>A​(p.Glu2044Lys) variant causes a missense change. The variant allele was found at a frequency of 0.289 in 1,612,844 control chromosomes in the GnomAD database, including 70,502 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.29 ( 6533 hom., cov: 32)
Exomes 𝑓: 0.29 ( 63969 hom. )

Consequence

CDH23
NM_022124.6 missense

Scores

1
3
12

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: 3.85

Publications

41 publications found
Variant links:
Genes affected
CDH23 (HGNC:13733): (cadherin related 23) This gene is a member of the cadherin superfamily, whose genes encode calcium dependent cell-cell adhesion glycoproteins. The encoded protein is thought to be involved in stereocilia organization and hair bundle formation. The gene is located in a region containing the human deafness loci DFNB12 and USH1D. Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of this cadherin-like gene. Upregulation of this gene may also be associated with breast cancer. Alternative splice variants encoding different isoforms have been described. [provided by RefSeq, May 2013]
CDH23 Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 12
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Usher syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 1D
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0011279583).
BP6
Variant 10-71791212-G-A is Benign according to our data. Variant chr10-71791212-G-A is described in ClinVar as Benign. ClinVar VariationId is 46002.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.517 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDH23NM_022124.6 linkc.6130G>A p.Glu2044Lys missense_variant Exon 47 of 70 ENST00000224721.12 NP_071407.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDH23ENST00000224721.12 linkc.6130G>A p.Glu2044Lys missense_variant Exon 47 of 70 5 NM_022124.6 ENSP00000224721.9

Frequencies

GnomAD3 genomes
AF:
0.286
AC:
43472
AN:
152008
Hom.:
6526
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.265
Gnomad AMI
AF:
0.383
Gnomad AMR
AF:
0.332
Gnomad ASJ
AF:
0.213
Gnomad EAS
AF:
0.533
Gnomad SAS
AF:
0.243
Gnomad FIN
AF:
0.348
Gnomad MID
AF:
0.117
Gnomad NFE
AF:
0.266
Gnomad OTH
AF:
0.269
GnomAD2 exomes
AF:
0.309
AC:
76554
AN:
247484
AF XY:
0.297
show subpopulations
Gnomad AFR exome
AF:
0.264
Gnomad AMR exome
AF:
0.428
Gnomad ASJ exome
AF:
0.210
Gnomad EAS exome
AF:
0.529
Gnomad FIN exome
AF:
0.349
Gnomad NFE exome
AF:
0.269
Gnomad OTH exome
AF:
0.280
GnomAD4 exome
AF:
0.289
AC:
421828
AN:
1460718
Hom.:
63969
Cov.:
37
AF XY:
0.284
AC XY:
206636
AN XY:
726558
show subpopulations
African (AFR)
AF:
0.268
AC:
8952
AN:
33458
American (AMR)
AF:
0.418
AC:
18615
AN:
44532
Ashkenazi Jewish (ASJ)
AF:
0.212
AC:
5535
AN:
26122
East Asian (EAS)
AF:
0.575
AC:
22811
AN:
39660
South Asian (SAS)
AF:
0.227
AC:
19563
AN:
86106
European-Finnish (FIN)
AF:
0.347
AC:
18490
AN:
53290
Middle Eastern (MID)
AF:
0.161
AC:
930
AN:
5768
European-Non Finnish (NFE)
AF:
0.279
AC:
309557
AN:
1111446
Other (OTH)
AF:
0.288
AC:
17375
AN:
60336
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
16621
33242
49863
66484
83105
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10692
21384
32076
42768
53460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.286
AC:
43495
AN:
152126
Hom.:
6533
Cov.:
32
AF XY:
0.290
AC XY:
21542
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.265
AC:
11010
AN:
41508
American (AMR)
AF:
0.332
AC:
5072
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.213
AC:
739
AN:
3472
East Asian (EAS)
AF:
0.534
AC:
2756
AN:
5164
South Asian (SAS)
AF:
0.243
AC:
1174
AN:
4826
European-Finnish (FIN)
AF:
0.348
AC:
3691
AN:
10594
Middle Eastern (MID)
AF:
0.126
AC:
37
AN:
294
European-Non Finnish (NFE)
AF:
0.266
AC:
18107
AN:
67972
Other (OTH)
AF:
0.266
AC:
560
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1601
3202
4804
6405
8006
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
446
892
1338
1784
2230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.272
Hom.:
14382
Bravo
AF:
0.290
TwinsUK
AF:
0.290
AC:
1076
ALSPAC
AF:
0.280
AC:
1079
ESP6500AA
AF:
0.270
AC:
1189
ESP6500EA
AF:
0.263
AC:
2258
ExAC
AF:
0.300
AC:
36393
Asia WGS
AF:
0.348
AC:
1212
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 08, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jun 12, 2009
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 30, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Usher syndrome type 1D Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Autosomal recessive nonsyndromic hearing loss 12 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Usher syndrome type 1 Benign:1
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Retinitis pigmentosa-deafness syndrome Benign:1
May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.42
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.014
T;T
Eigen
Benign
-0.072
Eigen_PC
Benign
0.13
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Benign
0.69
T;T
MetaRNN
Benign
0.0011
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.72
.;N
PhyloP100
3.8
PrimateAI
Uncertain
0.51
T
REVEL
Benign
0.18
Sift4G
Uncertain
0.041
D;.
Polyphen
0.64
.;P
Vest4
0.48
ClinPred
0.022
T
GERP RS
5.9
Varity_R
0.13
gMVP
0.64
Mutation Taster
=78/22
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10466026; hg19: chr10-73550969; COSMIC: COSV56449572; COSMIC: COSV56449572; API